CALCULATE YOUR SIP RETURNS

Stocks/Share Market - Angel One

Philogen and Sun Pharma’s Nidlegy™ Advances in European Cancer Treatment

Philogen and Sun Pharma’s Nidlegy™ Advances in European Cancer Treatment

4 July 2024

On July 4, 2024, Philogen S.p.A. ( and Sun Pharmaceutical Industries Limited announced via a stock exchange filing that the European Medicines Agency (EMA) had accepted their application to approve Nidlegy™. The application was submitted on June 3, and it has now entered the validation phase by the EMA. “The validation of the dossier by …

Dalmia Cement (Bharat) Ltd Begins 1.0 MTPA Production in Kadapa, AP

Dalmia Cement (Bharat) Ltd Begins 1.0 MTPA Production in Kadapa, AP

4 July 2024

On July 04, 2024, Dalmia Bharat Limited announced via a stock exchange filing that Dalmia Cement (Bharat) Limited, a wholly-owned subsidiary of Dalmia Bharat Limited, commenced commercial production of 1.0 MTPA at a new cement mill within its existing Kadapa, Andhra Pradesh plant, effective July 3, 2024. This expansion brings the company’s total capacity to …

Paytm Launches ‘Paytm Health Saathi’ to Empower Merchant Partners with Healthcare

Paytm Launches ‘Paytm Health Saathi’ to Empower Merchant Partners with Healthcare

4 July 2024

One 97 Communications Limited (OCL), the parent company of Paytm, India’s leading digital payments and financial services platform, has launched a new initiative, ‘Paytm Health Saathi,’ specifically designed for its merchant partners. ‘Paytm Health Saathi’ is an exclusive health and income protection plan available through the ‘Paytm for Business’ app. Supporting Merchant Wellbeing and Business …

Infosys Foundation and ICT Academy Collaborate to Enhance Rural Youth Employability

Infosys Foundation and ICT Academy Collaborate to Enhance Rural Youth Employability

4 July 2024

On July 3, 2024, Infosys Ltd announced via a stock exchange filing that its philanthropic and CSR arm, Infosys Foundation, has entered into a Memorandum of Understanding (MoU) with the ICT Academy of Tamil Nadu, a non-profit organisation. The collaboration aims to enhance the employability of young learners in rural India. Under this partnership, the …

Pearson and Veranda Race Launch Comprehensive Bank PO Exam Prep

Pearson and Veranda Race Launch Comprehensive Bank PO Exam Prep

4 July 2024

On July 3, 2024, Pearson, a leading global learning company, strengthened its partnership with Veranda Race, a well-known test preparation provider. Together, they are launching comprehensive and hybrid test prep content for Bank Probationary Officer (Bank PO) exams in India. Over 3 million students prepare for these exams annually. The new series includes 8 books …

How Go Digit IPO Performed in the Past 1 Month?

How Go Digit IPO Performed in the Past 1 Month?

4 July 2024

Insurance provider Go Digit General Insurance Limited raised ₹2,614.65 crore via an Initial Public Offering (IPO) that was open from May 15 to May 17, 2024. On Day 3, the Go Digit IPO witnessed a total subscription of 9.60x. The public issue subscribed 4.27x in the retail category, 12.56x in QIB, and 7.24x in the …

Promoter Italian Thai Development Considers Divesting ITD Cementation Stake

Promoter Italian Thai Development Considers Divesting ITD Cementation Stake

4 July 2024

Italian Thai Development is considering selling its stake in ITD Cementation after seeing a 252% rally in the stock over the past year.ITD Cementation informed the stock exchange on July 3, 2024, that his promotor company, Italian-Thai Development Public Company Ltd., wanted to sell his stake in the company. The promotion company, Italian-Thai Development, has …

Alembic Pharmaceuticals Secures US FDA Tentative Approval for Ivosidenib Tablets, 250 mg

Alembic Pharmaceuticals Secures US FDA Tentative Approval for Ivosidenib Tablets, 250 mg

4 July 2024

Alembic Pharmaceuticals Limited has informed the stock exchanges that the company has obtained tentative approval from the US Food & Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) concerning Ivosidenib Tablets, 250 mg. This approved ANDA is deemed therapeutically equivalent to Tibsovo Tablets, 250 mg, the reference listed drug product (RLD) marketed …

Marico Partners with Kaya to Expand Personal Care Product Reach

Marico Partners with Kaya to Expand Personal Care Product Reach

4 July 2024

Marico Limited announced in a stock exchange filing that it has partnered with Kaya. Marico will exclusively handle the sales and marketing of Kaya’s extensive range of over 75 science-based personal care products outside of Kaya’s clinics. This collaboration aims to leverage both companies’ established expertise and capabilities, unlocking untapped growth potential by enhancing the …

7 Essential Policy Rates That Can Make or Break Your Bond Investments

7 Essential Policy Rates That Can Make or Break Your Bond Investments

15 July 2024

The Reserve Bank of India’s policy rates have a significant impact on fixed income returns. The key policy rates that make a significant impact on the fixed income market prices and their yields. The list of the policy rates and their current values as of July 2024 are as follows: Repo Rate: 6.50% Standing Deposit …

Open Free Demat Account!

Join our 3 Cr+ happy customers

+91
Open Free Demat Account!
Join our 3 Cr+ happy customers